Clinical, Epidemiological, and Molecular Heterogeneity in Acral Melanoma

Cristina Carrera; Joan Anton Puig-Butille

doi:10.1016/j.jid.2017.09.027

Clinical, Epidemiological, and Molecular Heterogeneity in Acral Melanoma

J Invest Dermatol. 2018 Feb;138(2):254-255. doi: 10.1016/j.jid.2017.09.027.

Authors

Cristina Carrera¹, Joan Anton Puig-Butille²

Affiliations

¹ Melanoma Unit, Dermatology Department, Hospital Clínic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain.
² Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Electronic address: japuig@clinic.cat.

PMID: 29389327
DOI: 10.1016/j.jid.2017.09.027

Abstract

Acral melanoma comprises a poorly characterized and distinct type of melanoma, in terms of differing roles of UVR, molecular substrate, distribution among all ethnicities, and poor prognosis. Haugh et al. explore clinical, histological, and molecular aspects of acral melanomas and provide insights into the complexity of these tumors.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Melanoma*
Skin Neoplasms*